Veradigm (NASDAQ:MDRX) Now Covered by Analysts at StockNews.com

StockNews.com began coverage on shares of Veradigm (NASDAQ:MDRXFree Report) in a report issued on Sunday morning. The firm issued a hold rating on the software maker’s stock.

Veradigm Trading Down 2.3 %

MDRX stock opened at $10.44 on Friday. The business’s fifty day moving average price is $9.63 and its 200 day moving average price is $9.37. Veradigm has a 12-month low of $5.01 and a 12-month high of $12.79.

Institutional Trading of Veradigm

A hedge fund recently bought a new stake in Veradigm stock. Tyro Capital Management LLC bought a new position in shares of Veradigm Inc. (NASDAQ:MDRXFree Report) during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor bought 1,176,015 shares of the software maker’s stock, valued at approximately $9,055,000. Veradigm makes up 5.2% of Tyro Capital Management LLC’s holdings, making the stock its 10th biggest position. Tyro Capital Management LLC owned 1.08% of Veradigm as of its most recent SEC filing.

About Veradigm

(Get Free Report)

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.

Further Reading

Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.